Navigation Links
IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
Date:6/24/2010

SEATTLE, June 25 /PRNewswire-USNewswire/ -- Two global health non-profit organizations headquartered in Seattle, Washington, the Infectious Disease Research Institute (IDRI) and PATH, have entered into a Research Collaboration Agreement to evaluate novel adjuvants for their ability to enhance the immune response of pandemic influenza vaccines in development. The collaboration supports the goal of PATH's influenza vaccine project to advance the development of promising new influenza vaccines focusing on novel technologies that can be accessible, affordable, and available to people in low-resource countries in a global outbreak. IDRI, a non-profit biotechnology organization, has developed numerous emulsion adjuvants for use with various antigens for the production of vaccines.

Influenza vaccines, against both seasonal and pandemic influenza viruses, are especially needed in developing countries where current influenza vaccines may be unavailable or unaffordable, especially in the quantities needed during a pandemic outbreak. "Adjuvants, or immunostimulants, could be used to increase the worldwide supply of influenza vaccines, and may be crucial to provide the necessary doses in the event of a pandemic," says IDRI's Founder and Head of Research and Development Dr. Steve Reed.

Under the Research Collaboration Agreement, PATH will sponsor research at IDRI to evaluate different emulsions that may work as effective adjuvants in influenza vaccines for pandemic use. IDRI will provide its proprietary emulsion formulations, and PATH, through its collaborators, will provide IDRI with vaccine candidates for evaluation with various formulations. IDRI will then conduct the studies to identify leading vaccine-adjuvant candidates.  

"We are
'/>"/>

SOURCE Infectious Disease Research Institute (IDRI)
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform
2. Concord Medical Announces New Centers Opening at Hospital Partner
3. Zydus Novel Orally Administered GLP-1 Agonist - ZYOG1 to treat Diabetes and Obesity Enters Phase I Clinical Trial
4. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
5. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
6. Varian Medical Systems Equips International Oncologys First Comprehensive Cancer Center in India
7. New York State Regional Extension Center Selects Greenway
8. Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center
9. Maimonides Medical Center Implements Allscripts Care Management Solution
10. New Georgia Advanced Surgery Center Provides Women Many Unique Benefits
11. New Technology Center Increases B. Brauns Infusion Pump Capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Ameritox, the nation,s leader in pain medication ... to become part of its Urine Drug Monitoring ... and improve the clinical outcomes for injured workers. ... manager in the workers, compensation industry, has used ... management strategy for several years. By establishing a ...
(Date:5/23/2013)... 2013  BioElectronics Corporation (OTC Pink: BIEL), the maker ... the FDA panel meeting for non-thermal shortwave diathermy: ... Shortwave Therapy Meeting was held on May 21, 2013 ... focus of the meeting was very narrow, in that ... on the application of non-thermal shortwave diathermy for the ...
(Date:5/23/2013)... , May 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... for non-invasive patient monitoring, today announced that Thomas ... present at the 2 nd Annual Marcum MicroCap Conference ... in New York City . ... in the Estate 10 room and will be available via ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
(Date:5/23/2013)... May 23, 2013 Dr. Damon Huffman of ... suffer from gum disease a revolutionary new treatment method with ... millions of Americans who suffer from periodontal disease, and many ... treatment. Dr. Huffman is hoping that LANAP will encourage ... treatment. , Periodontal disease can cause gums ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Da Vinci ... in a trial in Washington State May 23, according ... clients in surgical robot lawsuits , expresses disappointment ... da Vinci lawsuits to not read a single verdict ... case (Estate of Fred E. Taylor v. Intuitive Surgical ...
(Date:5/23/2013)... 2013 Memorial Day Focus Spotlight on ... been a part of the U.S. Military for more ... preceding it, these men and women will be honored ... of America. As veterans transition to civilian life, ... the workplace chaplaincy world. , Marketplace Chaplains, America’s ...
(Date:5/23/2013)... Live Lead Pros , with ... best business lead solution via its smart solution ... solution features Free Web Based Account Management, Database ... and "Automatic Transfer Retry". The company has recently ... management system. , Its Free Database Usage offers ...
(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...
Breaking Medicine News(10 mins):Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... 26, 2008 Adding noninvasive imaging to current risk-assessment ... of developing heart disease, UT Southwestern Medical Center researchers ... Southwestern-led Dallas Heart Study to determine whether using computed ... and blockages could identify more people at high risk ...
... Desso ... Turf, BRUSSELS, Belgium, May ... a few synthetic turf,fields. The fields in question are not manufactured by Desso ... that,their pitch doesn,t contain any lead., All Desso synthetic turf products and ...
... the clumps of mutant protein that drive neurodegeneration in ... make an intracellular antibody or "intrabody" against huntingtin, the ... people with Huntington,s. , Injecting the virus into the ... ability to move their limbs, although it does not ...
... mapmaker and a mathematician may seem like an unlikely duo, ... and kept millions of sailors from getting lost at ... at Rockefeller University, is making history of their own. By ... they have become the first to see, in real time ...
... Corporate Seminars Caught In Crossfire, SAN FRANCISCO, ... is not a party to a lawsuit that ... international training and,development company is inappropriately referenced in ... suit, filed by Scott Glasgow, is claiming sexual,harassment ...
... First we knew, then we didn,t. A factor, ... egg is crucial for promoting the oscillations in free ... activation processes. Phospholipase C zeta (PLCZ1) is a strong ... the zygotes pronuclei where its ability to promote calcium ...
Cached Medicine News:Health News:Increased screening may better predict those at higher risk for heart disease, researchers report 2Health News:It's Safe to Play on Desso Synthetic Turf 2Health News:It's Safe to Play on Desso Synthetic Turf 3Health News:'Intrabody' can mop up mutant protein in Huntington's disease model 2Health News:Scientists image a single HIV particle being born 2Health News:Scientists image a single HIV particle being born 3Health News:International Training and Development Company, Landmark Education, Mischaracterized as Religion 2Health News:June 2008 highlights 2
... Vision5L Digital Holter ... or 7-lead, 3-channel,Holter ... signal preview,screen. Fast ... a compact,flash card ...
... The CSV-1000CVA20/30 test face provides three contrast levels ... from 20/16 to 20/100. This test is designed ... as associated with contact lens evaluation or due ... the test provide the same contrast and acuity ...
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
Medicine Products: